Stock Events

Stock Events

VolitionRX 

$1.2000
27
-$0.07-5.51% 08:00 Today

Statistics

Day High
1.19
Day Low
1.18
52W High
16
52W Low
1.16
Volume
1,533
Avg. Volume
-
Mkt Cap
14.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.97
-0.66
-0.35
-0.04
Expected EPS
-0.606
Actual EPS
N/A

Financials

-1,352.46%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.73MRevenue
-23.36MNet Income

Analyst Ratings

2.67Average Price Target
The highest estimate is 4.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VNRX. It's not an investment recommendation.
Coca-Cola
6
KO
Alibaba Group
6
BABA
Apple
5
AAPL
Realty Income
5
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.22B
Guardant Health, Inc. specializes in liquid biopsy tests, a similar market niche to VolitionRX's blood-based cancer detection tests.
Grifols SA
GRFS
Mkt Cap4.95B
Grifols, S.A. provides a range of diagnostic solutions, including for cancer, competing in the broader diagnostic market alongside VolitionRX.
Qiagen NV
QGEN
Mkt Cap8.56B
Qiagen N.V. offers molecular diagnostics and sample preparation technologies, competing in the cancer diagnostics and research market.
Fulgent Genetics
FLGT
Mkt Cap583.63M
Fulgent Genetics, Inc. provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics space.
Pacific Biosciences of California
PACB
Mkt Cap484.54M
Pacific Biosciences of California, Inc. develops sequencing systems, indirectly competing by advancing cancer research and potentially diagnostics.
Illumina
ILMN
Mkt Cap28.78B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, competing in the broader genomics and diagnostics market.
TG Therapeutics
TGTX
Mkt Cap8.74B
TG Therapeutics, Inc. focuses on developing treatments for B-cell malignancies and autoimmune diseases, indirectly competing by targeting cancer treatment and diagnosis.

About

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Show more...
CEO
Mr. Cameron Reynolds MBA
Employees
75
Country
United States
ISIN
US9286612067

Listings

XASE
US
VNRX
BOATS
BOATS
VNRX.BOATS

0 Comments

Share your thoughts

FAQ

What is VolitionRX stock price today?▼
The current price of VNRX is $1.20 USD — it has decreased by -5.51% in the past 24 hours. Watch VolitionRX stock price performance more closely on the chart.
What is VolitionRX stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange VolitionRX stocks are traded under the ticker VNRX.
Is VolitionRX stock price growing?▼
VNRX stock has fallen by -11.94% compared to the previous week, the month change is a -15.71% fall, over the last year VolitionRX has showed a -91.57% decrease.
What is VolitionRX market cap?▼
Today VolitionRX has the market capitalization of 14.07M
When is the next VolitionRX earnings date?▼
VolitionRX is going to release the next earnings report on August 19, 2026.
What were VolitionRX earnings last quarter?▼
VNRX earnings for the last quarter are -0.97 USD per share, whereas the estimation was -0.73 USD resulting in a -32.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is VolitionRX revenue for the last year?▼
VolitionRX revenue for the last year amounts to 1.73M USD.
What is VolitionRX net income for the last year?▼
VNRX net income for the last year is -23.36M USD.
How many employees does VolitionRX have?▼
As of July 16, 2026, the company has 75 employees.
In which sector is VolitionRX located?▼
VolitionRX operates in the Health & Wellness sector.
When did VolitionRX complete a stock split?▼
The last stock split for VolitionRX was on April 28, 2026 with a ratio of 1:20.
Where is VolitionRX headquartered?▼
VolitionRX is headquartered in Henderson, United States.